Records containing: Migraine
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-10-28A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Erenumab in Children (6 to < 12 Years) and Adolescents (12 to < 18 Years) With Chronic Migraine (OASIS PEDIATRIC [CM])
-
CLINICAL_TRIALS study record update · 2026-10-14A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Erenumab in Children (6 to < 12 Years) and Adolescents (12 to < 18 Years) With Episodic Migraine (OASIS PEDIATRIC [EM])
-
CLINICAL_TRIALS study record update · 2026-09-21A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Erenumab in Children (6 to < 12 Years) and Adolescents (12 to < 18 Years) With Episodic Migraine (OASIS PEDIATRIC [EM])
-
CLINICAL_TRIALS study record update · 2026-09-11Randomized, Double-blind, Placebo-Controlled, Multiple-Attack Study With an Open-Label Extension to Evaluate the Efficacy, Safety, Tolerability, and the Consistency of Effect of Atogepant for the Acute Treatment of Migraine (ECLIPSE)
-
CLINICAL_TRIALS study record update · 2026-07-02A Randomized, Double-Blind, Parallel-Group, Active Controlled Trial With Open-Label Safety Extension to Evaluate the Tolerability, Safety, and Efficacy of Atogepant Versus Topiramate in Subjects Requiring Preventive Treatment of Migraine (TEMPLE)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-27Prospective, Randomized, Double-blinded, Placebo-controlled, Cross-over Trial of Endoscopically Guided Injection of Exparel (Bupivacaine) Towards the Ipsilateral Pterygopalatine Fossa for the Treatment of Craniofacial Pain
-
CLINICAL_TRIALS study record update · 2026-04-24Patterned Multichannel Vibratory Coordinated Reset (VCR) Stimulation for the Treatment of Chronic Pain
-
CLINICAL_TRIALS study record update · 2026-04-22BE WELL With Migraine: Brain Education and WELLness With Migraine
-
CLINICAL_TRIALS study record update · 2026-04-22Investigation of Imagery Abilities in Individuals With Migraine and the Relationship Between Imagery Abilities and Proprioception, and Balance
-
CLINICAL_TRIALS study record update · 2026-04-22COMParison of the EffecT of mEdication Therapy: Anticoagulation Versus Anti-platelet Versus Migraine Therapy in Alleviating Migraine With Patent Foramen Ovale
-
CLINICAL_TRIALS study record update · 2026-04-21Treatment for Migraine and Mood (TEAM-M): A Randomized Controlled Trial of a Mindfulness-based Training Program
-
CLINICAL_TRIALS study record update · 2026-04-21BHV3000-406 (C4951004): A Phase 4, Randomized, Double-blind Placebo-Controlled, Efficacy and Tolerability Trial of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use
-
CLINICAL_TRIALS study record update · 2026-04-21Effect of Osteopathic Intervention on Migraine: A Randomised Controlled Trial
-
CLINICAL_TRIALS study record update · 2026-04-17Feasibility Study to Evaluate the Initial Safety and Effectiveness of TRUFILL n-BCA Liquid Embolic System in Middle Meningeal Artery Embolization for the Preventive Treatment of Refractory Chronic Migraine
-
CLINICAL_TRIALS study record update · 2026-04-17Double Blind Randomized Control Trial of Inhaled Isopropyl Alcohol Vapors Versus Inhaled Eucalyptus Scent for the Treatment of Nausea Associated With Acute Migraine
-
CLINICAL_TRIALS study record update · 2026-04-16A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant in Migraine Prevention in Children and Adolescents ≥ 6 to <18 Years of Age
-
CLINICAL_TRIALS study record update · 2026-04-15Interventional, Randomized, Double-blind, Parallel-group, Placebo-controlled, Dose-finding Trial of Lu AG09222 for the Prevention of Migraine in Participants With Unsuccessful Prior Preventive Treatments
-
CLINICAL_TRIALS study record update · 2026-04-15Long-term, Open-label (Dose-blinded), Extension Study of Eptinezumab in Children and Adolescents With Chronic or Episodic Migraine
-
CLINICAL_TRIALS study record update · 2026-04-15CEFALY Pregnancy Registry
-
CLINICAL_TRIALS study record update · 2026-04-14Randomized, Double-blind, Placebo-Controlled, Multiple-Attack Study With an Open-Label Extension to Evaluate the Efficacy, Safety, Tolerability, and the Consistency of Effect of Atogepant for the Acute Treatment of Migraine (ECLIPSE)
-
CLINICAL_TRIALS study record update · 2026-04-14Family Study of Affective and Anxiety Spectrum Disorders
-
CLINICAL_TRIALS study record update · 2026-04-13AN INTERVENTIONAL, EFFICACY, AND SAFETY, PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY WITH AN OPEN-LABEL EXTENSION TO INVESTIGATE RIMEGEPANT IN MIGRAINE PREVENTION IN ADOLESCENTS 12 TO LESS THAN 18 YEARS OF AGE WITH CHRONIC MIGRAINE
-
CLINICAL_TRIALS study record update · 2026-04-13Nurse Intervention Trial: The Evaluation of Usefulness of a Headache Nurse
-
CLINICAL_TRIALS study record update · 2026-04-13New Methods for Evaluating Preventive Migraine Treatment
-
CLINICAL_TRIALS study record update · 2026-04-09Investigating the inFluence of EndoMetriosis IN migraINE - FEMININE Study